» Articles » PMID: 23741357

Missense Mutation in CAPN1 is Associated with Spinocerebellar Ataxia in the Parson Russell Terrier Dog Breed

Overview
Journal PLoS One
Date 2013 Jun 7
PMID 23741357
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Spinocerebellar ataxia (SCA) in the Parson Russell Terrier (PRT) dog breed is a disease of progressive incoordination of gait and loss of balance. Clinical signs usually become notable between 6 and 12 months of age with affected dogs presenting with symmetric spinocerebellar ataxia particularly evident in the pelvic limbs. The degree of truncal ataxia, pelvic limb hypermetria and impaired balance is progressive, particularly during the initial months of disease. A certain degree of stabilisation as well as intermittent worsening may occur. At the later stages of the disease ambulation often becomes difficult, with owners often electing to euthanise affected dogs on welfare grounds. Using a GWAS approach and target-enriched massively-parallel sequencing, a strongly associated non-synonymous SNP in the CAPN1 gene, encoding the calcium dependent cysteine protease calpain1 (mu-calpain), was identified. The SNP is a missense mutation causing a cysteine to tyrosine substitution at residue 115 of the CAPN1 protein. Cysteine 115 is a highly conserved residue and forms a key part of a catalytic triad of amino acids that are crucial to the enzymatic activity of cysteine proteases. The CAPN1 gene shows high levels of expression in the brain and nervous system and roles for the protein in both neuronal necrosis and maintenance have been suggested. Given the functional implications and high level of conservation observed across species, the CAPN1 variant represents a provocative candidate for the cause of SCA in the PRT and a novel potential cause of ataxia in humans.

Citing Articles

Revisiting the calpain hypothesis of learning and memory 40 years later.

Baudry M, Bi X Front Mol Neurosci. 2024; 17:1337850.

PMID: 38361744 PMC: 10867166. DOI: 10.3389/fnmol.2024.1337850.


An Overview of Canine Inherited Neurological Disorders with Known Causal Variants.

Cocostirc V, Pastiu A, Pusta D Animals (Basel). 2023; 13(22).

PMID: 38003185 PMC: 10668755. DOI: 10.3390/ani13223568.


Generalized myokymia, or neuromyotonia, or both in dogs with or without spinocerebellar ataxia.

Vanhaesebrouck A, Van Poucke M, Stee K, Granger N, Ives E, Van Soens I J Vet Intern Med. 2023; 37(6):2310-2314.

PMID: 37905444 PMC: 10658559. DOI: 10.1111/jvim.16892.


A SACS deletion variant in Great Pyrenees dogs causes autosomal recessive neuronal degeneration.

Ekenstedt K, Minor K, Shelton G, Hammond J, Miller A, Taylor S Hum Genet. 2023; 142(11):1587-1601.

PMID: 37758910 PMC: 10602964. DOI: 10.1007/s00439-023-02599-1.


Calpain signaling: from biology to therapeutic opportunities in neurodegenerative disorders.

Metwally E, Al-Abbadi H, Hussain T, Murtaza G, Abdellatif A, Ahmed M Front Vet Sci. 2023; 10:1235163.

PMID: 37732142 PMC: 10507866. DOI: 10.3389/fvets.2023.1235163.


References
1.
Henikoff S, Henikoff J . Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A. 1992; 89(22):10915-9. PMC: 50453. DOI: 10.1073/pnas.89.22.10915. View

2.
Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

3.
Faddis B, Hasbani M, Goldberg M . Calpain activation contributes to dendritic remodeling after brief excitotoxic injury in vitro. J Neurosci. 1997; 17(3):951-9. PMC: 6573163. View

4.
Dutt P, Croall D, Arthur J, De Veyra T, Williams K, Elce J . m-Calpain is required for preimplantation embryonic development in mice. BMC Dev Biol. 2006; 6:3. PMC: 1382200. DOI: 10.1186/1471-213X-6-3. View

5.
Perkins E, Clarkson Y, Sabatier N, Longhurst D, Millward C, Jack J . Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans. J Neurosci. 2010; 30(14):4857-67. PMC: 2857506. DOI: 10.1523/JNEUROSCI.6065-09.2010. View